Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 25 Pancreatic Neoplasms 19 Neoplasm Metastasis 17 Neuroblastoma 8 Lung Neoplasms 6 Rhabdomyosarcoma 5 Rectal Neoplasms 5 Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Colonic Neoplasms 5 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Sarcoma, Ewing 4 Sarcoma 4 Esophageal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Wilms Tumor 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Glioma 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2

Interventions

PM 01183 2 Cyclophosphamide 2 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 Vinorelbine 1 Ramucirumab 1 Mesna 1 Irinotecan 1 CLR1404 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoplastic Small Round Cell Tumor × Irinotecan × 90 days × Clear all

NCT07328425 2026-04-03

ISG-TULIPS

Italian Sarcoma Group

Phase 2 Recruiting

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡